Volatility Spike may Give way to Opportunity in Biotech ETFs
August 31, 2015 at 09:30 AM EDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotech ETF by assets, and other biotech ETFs proved vulnerable to the broader market’s recent surge in volatility, but the declines endured by IBB and friends could prove to be a buying opportunity for astute investors. Given...